Filter
2236
Filtered Results: 2236
Text search:
TB
disease
burden
Featured
Recommendations
202
New Publications
655
Language
Document type
No document type
1477
Studies & Reports
347
Guidelines
212
Strategic & Response Plan
77
Manuals
60
Fact sheets
29
Training Material
16
Situation Updates
11
Infographics
3
Brochures
2
Resource Platforms
2
Countries / Regions
India
113
Kenya
92
South Africa
83
Western and Central Europe
77
Global
70
Uganda
56
Tanzania
53
Ethiopia
52
Africa
49
Malawi
46
Nigeria
44
Zambia
43
Nepal
40
Namibia
40
Eastern Europe
40
Sierra Leone
38
Liberia
36
Ghana
34
Rwanda
33
Bangladesh
30
Ukraine
29
Myanmar / Burma
27
South–East Asia Region
25
Asia
25
Lesotho
24
Cambodia
23
Latin America and the Carribbean
23
Zimbabwe
19
Philippines
16
Russia
15
Mozambique
14
Botswana
14
Eswatini/ Swaziland
10
East and Southern Africa
10
Pakistan
9
South Sudan
9
Germany
9
Indonesia
9
Congo, Democratic Republic of
8
Senegal
7
Syria
7
Haiti
6
Brazil
6
West and Central Africa
6
Sudan
5
Colombia
5
Middle East and North Africa
5
Georgia
5
Guinea
4
Jordan
4
Afghanistan
4
Thailand
4
Argentina
4
Peru
4
Western Pacific Region
4
Eastern Europe and Central Asia
4
Albania
4
Southern Africa
4
Timor Leste/ East Timor
4
Tajikistan
4
Iran
4
Vietnam
4
USA
3
Cameroon
3
Somalia
3
Lebanon
3
Papua New Guinea
3
Ecuador
3
Sri Lanka
3
Venezuela
3
Armenia
3
Laos
3
North America
3
Saudi Arabia
2
Iraq
2
Benin
2
Central African Republic
2
North Macedonia
2
Burundi
2
Angola
2
Yemen
2
Paraguay
2
Bhutan
2
Romania
2
Burkina Faso
1
Morocco
1
Egypt
1
Gambia
1
Ireland
1
El Salvador
1
Bolivia
1
Greece
1
Libya
1
Chile
1
Poland
1
Palestine
1
North Korea
1
Djibouti
1
Qatar
1
Bulgaria
1
Estonia
1
Moldova
1
Gabon
1
Turkmenistan
1
Jamaica
1
Belgium
1
Maldives
1
Tunisia
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
978
Clinical Guidelines
171
Public Health
103
Women & Child Health
46
Key Resources
35
Pharmacy & Technologies
18
Capacity Building
17
Annual Report MEDBOX
2
Toolboxes
TB
505
HIV
322
AMR
92
COVID-19
83
Mental Health
54
Caregiver
41
Global Health Education
40
NTDs
38
NCDs
35
Refugee
31
Health Financing Toolbox
28
Pharmacy
24
Conflict
22
Planetary Health
21
Disability
18
Ebola
16
Rapid Response
16
Polio
15
Natural Hazards
13
Social Ethics
5
Cholera
3
Zika
2
Specific Hazards
2
South Sudan
1
Health Financing
1
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
Mpox is an emerging zoonotic disease caused by the mpox virus, a member of the Orthopoxvirus genus closely related to the variola virus that causes smallpox. Mpox was first discovered in 1958 when outbreaks of a pox-like ... occurred in monkeys kept for research. The first human case was recorded in 1970 in the Democratic Republic of the Congo (DRC) during a period of intensified effort to eliminate smallpox and since then the infection has been reported in a number of African countries. Mpox can spread in humans through close contact, usually skin-to-skin contact, including sexual contact, with an infected person or animal, as well as with materials contaminated with the virus such as clothing, beddings and towels, and respiratory droplets in prolonged face to face contact. People remain infectious from the onset of symptoms until all the lesions have scabbed and healed. The virus may spread from infected animals through handling infected meat or through bites or scratches. Diagnosis is confirmed by polymerase chain reaction (PCR) testing of material from a lesion for the virus’s DNA. Two separate clades of the mpox virus are currently circulating in Africa: Clade I, which includes subclades Ia and Ib, and Clade II, comprising subclades IIa and IIb. Clade Ia and Clade Ib have been associated with ongoing human-to-human transmission and are presently responsible for outbreaks in the Democratic Republic of the Congo (DRC), while Clade Ib is also contributing to outbreaks in Burundi and other countries.
In 2022‒2023 mpox caused a global outbreak in over 110 countries, most of which had no previous history of the disease, primarily driven by human-to-human transmission of clade II through sexual contact. In just over a year, over 90,000 cases and 150 deaths were reported to the WHO. For the second time since 2022, mpox has been declared a global health emergency as the virus spreads rapidly across the African continent. On 13 Aug 2024, Africa CDC declared the ongoing mpox outbreak a Public Health Emergency of Continental Security (PHECS), marking the first such declaration by the agency since its inception in 2017.7 This declaration empowered the Africa CDC to lead and coordinate responses to the mpox outbreak across affected African countries. On August 14, 2024, the WHO declared the resurgence of mpox a Public Health Emergency of International Concern (PHEIC) emphasizing the need for coordinated international response.
As of August 2024, Mpox has expanded beyond its traditional endemic regions, with new cases reported in countries including Sweden, Thailand, the Philippines, and Pakistan. Sweden has confirmed its first case of Clade 1 variant, which has been rapidly spreading in Africa, particularly in DRC. The emergence of this new variant raises concerns about its potential for higher lethality and transmission rates outside Africa.
Mission report April 2016
8 March 2022
A very large number of people from Ukraine are fleeing the country and entering the European Union (EU) countries bordering Ukraine (Hungary, Poland, Romania, Slovakia) and the EU-neighbourhood country of the Republic of Moldova. Those fleeing Ukraine - mainly women and children - are ...
This document aims to provide guidance to healthcare facilities and healthcare providers in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) on preparedness and infection prevention and control (IPC) measures for the management of possible and confirmed cases of COVID-1...
Evaluation report
September 2014
Глобальная статистика свидетельствует о том, что бремя туберкулеза более актуально в городских регионах. Тем не менее, в тех странах, где большая часть населения п...
Downloaded from https://aidsinfo.nih.gov/guidelines on 11/27/2019
Visit the AIDSinfo website to access the most up-to-date guideline.
Register for e-mail notification of guideline updates at https://aidsinfo.nih.gov/e-news.
The Infection Prevention and Control (IPC) Legal Framework comes before the Specialized Technical Committee on Health and Drug Control for adoption and endorsement. The IPC Legal Framework is designed to guide Member States in the review and strengthening of laws and policies that support IPC at bot...
Цель этого документа – повысить уровень осознания актуальности приоритетных направлений научных исследований по проблеме ТБ/ВИЧ (то есть по тем направлениям, кот...
Evaluation report
January 2014
This manual summarizes the methodology used to develop WHODAS 2.0 and the findings obtained when the schedule was applied to certain areas of general health, including mental and neurological disorders.
The manual will be useful to any researcher or clinician wishing to use WHODAS 2.0 in their prac...
Evaluation report
September 2014
